AnaptysBio, Inc. (NASDAQ: ANAB) reported Q4 EPS of ($1.59), $0.04 better than the analyst estimate of ($1.63). Revenue for the quarter came in at $0 versus the consensus estimate of $3.83 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.